Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study

Figure 1

Primary outcome measures at baseline and following 4 and 12 weeks of MC use. (a) YGTSS-TS (score 0-50). (b) YGTSS-I (score 0-50). (c) YGTSS-Total (score 0-100). (d) PUTS (score 4-36). Compared to baseline. ^†, 3 subjects failed to complete midtrial evaluation, 3 subjects terminated the trial prematurely. ^‡. Abbreviations: MC: medical cannabis; YGTSS-TS: Yale Global Tic Severity Scale Tic Score; TGYSS-I: Yale Global Tic Severity Scale Impairment; PUTS: Premonitory Urge for Tic Scale.

(a)

(b)

(c)

(d)